Exclusive: Bridgepoint Group to Acquire Obagi Medical
The UK investment firm has agreed to purchase the clinical skincare label from Waldencast for $460 million, with co-founders Michel Brousset and Hind Sebti departing the beauty conglomerate to join Bridgepoint.
The Story
On Monday, UK investment firm Bridgepoint announced an agreement to acquire Obagi Medical from Waldencast for $460 million.
Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.
We believe privacy is a right, not a trade-off. Choose exactly what you're comfortable with. You can change these any time. Full privacy policy.
Essential
Always on
Required for the site to function
Session management, security tokens, login state, and your cookie preference itself. These cannot be turned off. No personal data is shared with third parties.
Analytics
Optional
Helps us understand what content you enjoy
We use anonymised analytics (e.g. Google Analytics) to see which articles perform well, how long people spend reading, and where traffic comes from. This helps us write better content. Your IP address is anonymised and no data is sold.
Personalisation
Optional
Remembers your preferences across visits
Remembers your reading preferences and recently read articles so we can surface relevant content. All data stays in your browser — nothing is sent to our servers.
Advertising
Optional
Used to show relevant ads that support the site
Allows advertising partners to show you ads based on your interests. If you decline, you'll still see ads but they won't be tailored to you. We work with Google AdSense and similar networks. You can opt out globally at youronlinechoices.eu.
Continue reading
You're clearly a fan
Get the best stories in your inbox
Join thousands of readers who get XOTLIST delivered daily. No spam, ever. Unsubscribe anytime.
